UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2024
Commission File Number: 001-41641
SHL TELEMEDICINE LTD.
SHL TELEMEDICINE LTD.
(Translation of registrant’s name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On August 2, 2024, SHL Telemedicine
Ltd. (the “Company”) issued a press release, a copy of which is
furnished herewith as Exhibit 99.1. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed
with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).
| Exhibit | Description |
| 99.1 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.
|
SHL Telemedicine Ltd.
|
|||
|
By:
|
/s/ Amir Hai | ||
| Amir Hai | |||
| Chief Financial Officer | |||
August 2, 2024